DUET-2
Showing 1 - 25 of >10,000
Merkel Cell Carcinoma, Small Cell Lung Cancer Trial in United States (XmAb18087, XmAb18087 ± Pembrolizumab)
Completed
- Merkel Cell Carcinoma
- Small Cell Lung Cancer
- XmAb18087
- XmAb18087 ± Pembrolizumab
-
Duarte, California
- +6 more
Aug 8, 2022
The Diagnostic Ultrasound Enthesitis Tool (DUET) Study
Unknown status
- Psoriatic Arthritis
- +2 more
- Musculoskeletal Ultrasound
-
Toronto, Ontario, CanadaWomen's College Hospital
Dec 8, 2020
NASH - Nonalcoholic Steatohepatitis Trial in San Antonio (TERN-501, TERN-101, Placebo)
Recruiting
- NASH - Nonalcoholic Steatohepatitis
- TERN-501
- +2 more
-
Chandler, Arizona
- +21 more
Jan 6, 2023
COPD Exacerbation, Hypercapnia, COPD Trial in Athens, Larissa (Asymmetric nasal cannula - DUET, Conventional nasal high flow
Not yet recruiting
- COPD Exacerbation
- +2 more
- Asymmetric nasal cannula - DUET
- Conventional nasal high flow cannula
-
Athens, Greece
- +1 more
Apr 24, 2023
Hypoxemia Trial in Padova (Symmetrical high flow nasal cannula (HFNO), Asymmetrical high flow nasal cannula (DUET HFNO))
Recruiting
- Hypoxemia
- Symmetrical high flow nasal cannula (HFNO)
- Asymmetrical high flow nasal cannula (DUET HFNO)
-
Padova, ItalyInstitute of Anaesthesia and Intensive Care, Padua University ho
Apr 20, 2023
COPD Trial in Essen (AIRVO 2)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- AIRVO 2
-
Essen, NRW, GermanyGeorg N Nilius
Dec 22, 2022
Melanoma (Excluding Uveal Melanoma), Cervical Carcinoma, Pancreatic Carcinoma Trial in United States (XmAb®23104, Yervoy®
Recruiting
- Melanoma (Excluding Uveal Melanoma)
- +15 more
- XmAb®23104
- Yervoy® (ipilimumab)
-
San Diego, California
- +15 more
Sep 20, 2021
Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)
Completed
- Melanoma
- +27 more
- XmAb20717
-
Los Angeles, California
- +16 more
Nov 29, 2022
Spine Deformity Trial in Nanjing (double rods without dual-headed screw, three rods with one dual-headed screw, four rods with
Recruiting
- Spine Deformity
- double rods without dual-headed screw
- +2 more
-
Nanjing, Jiangsu, ChinaNanjing Drum Tower Hospital
Nov 17, 2023
Patients Who Received Etravirine and/or Darunavir
Recruiting
- HIV/AIDS
-
Yaounde, Centre Region, Cameroon
- +4 more
Mar 22, 2022
Selecting the SSV-1 as LIV in Scheuermann's Kyphosis
Completed
- Scheuermann's Kyphosis
- Select the vertebra above sagittal stable vertebra as the distal fusion level
-
Nanjing, Jiang Su, ChinaDrum Tower Hospital of Nanjing University Medical School
Jul 18, 2023
Smoking, Cigarette, Electronic Cigarette Use Trial in Providence (Cue Reactivity Task, Computerized Visual Dot Probe, Choice
Recruiting
- Smoking, Cigarette
- Electronic Cigarette Use
- Cue Reactivity Task
- +2 more
-
Providence, Rhode IslandCenter for Alcohol and Addiction Studies
Jan 30, 2023
Cancer, Overweight and Obesity Trial in Birmingham (eHealth Intervention)
Active, not recruiting
- Cancer
- Overweight and Obesity
- eHealth Intervention
-
Birmingham, AlabamaUAB School of Health Professions, Department of Nutrition Scienc
Jun 9, 2022
COPD Trial in Philadelphia (myAirvo3, Pulse oximeter)
Recruiting
- COPD
- myAirvo3
- Pulse oximeter
-
Philadelphia, PennsylvaniaTemple University
Feb 21, 2022
Surgery Trial in Fuzhou (single-incision plus one-port laparoscopic surgery, conventional laparoscopic surgery)
Recruiting
- Surgery
- single-incision plus one-port laparoscopic surgery
- conventional laparoscopic surgery
-
Fuzhou, Fujian, ChinaFujian Cancer Hospital
Oct 4, 2021
Atherosclerosis Trial in São Paulo (Biomime Morph, a tapered drug eluting stent (DES) with hybrid design)
Completed
- Atherosclerosis
- Biomime Morph, a tapered drug eluting stent (DES) with hybrid design
-
São Paulo, BrazilInstituto do Coração - HCFMUSP
May 24, 2022
Gastric Cancer Trial in Seoul (da vinc SP gastrectomy)
Not yet recruiting
- Gastric Cancer
- da vinc SP gastrectomy
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
Sep 10, 2021
Crohn's Disease Trial in Worldwide (Guselkumab, Golimumab, JNJ-78934804)
Not yet recruiting
- Crohn's Disease
- Guselkumab
- +3 more
-
Birmingham, Alabama
- +167 more
Jul 14, 2022
Human Immunodeficiency Virus Trial in Italy (RPV + DRV/r, continue the PI/r-containing HAART.)
Completed
- Human Immunodeficiency Virus
- RPV + DRV/r
- continue the PI/r-containing HAART.
-
Bari, BA, Italy
- +11 more
Mar 31, 2020
Crohn Disease Trial in Evansville (JNJ-64304500, Placebo, Adalimumab)
Withdrawn
- Crohn Disease
- JNJ-64304500
- +3 more
-
Evansville, IndianaMedisphere Medical Research Center, Llc
Aug 30, 2021
Submassive Pulmonary Embolism Trial in Atlanta (catheter-directed thrombolysis)
Completed
- Submassive Pulmonary Embolism
- catheter-directed thrombolysis
-
Atlanta, GeorgiaPiedmont Healthcare
Sep 23, 2021
Antibody-mediated Rejection, Hyperacute Rejection of Cardiac Transplant, Left Ventricular Dysfunction Trial in Los Angeles
Completed
- Antibody-mediated Rejection
- +4 more
-
Los Angeles, CaliforniaCedars Sinai Medical Center, Heart Institute
Apr 30, 2021
Pulmonary Embolism Trial in Pittsburgh (CDT without ultrasound acceleration, CDT with ultrasound acceleration)
Completed
- Pulmonary Embolism
- CDT without ultrasound acceleration
- CDT with ultrasound acceleration
-
Pittsburgh, Pennsylvania
- +3 more
Sep 3, 2021
Colitis, Ulcerative Trial in Worldwide (Guselkumab, Golimumab, JNJ-78934804)
Not yet recruiting
- Colitis, Ulcerative
- Guselkumab
- +3 more
-
Arcadia, California
- +236 more
Jul 14, 2022